Does Mounjaro last longer than 30 days — and what happens if yours runs out early?

You've counted the days and something doesn't add up

It's a genuinely frustrating realisation. You've ordered your Mounjaro pen, you know it contains four doses, and then you notice that four weeks is 28 days, which means every calendar month you're either two or three days short, or you're placing your next order while there's still a dose to go. Neither feels quite right, and it's one of the more common things people bring to our prescribers.

The pen's design is intentional. Tirzepatide's pharmacokinetics (the way it moves through the body) are built around a seven-day dosing interval. That interval is not approximate. The licensed schedule specifies once weekly, and the four-dose pen gives you exactly that: four injections, seven days apart, 28 days total. There is no clinical basis for stretching it to 30 or 31 days by delaying a dose, and the NHS tirzepatide guidance is clear that dosing intervals should not be shortened below seven days either. If you want to understand the specific reasons the pen is designed this way, this page explains why Mounjaro is only a 30-day supply in more detail.

The practical upshot: if you inject on the same day each week, your fourth dose falls on day 22. The pen is then finished, and your next one should already be in the fridge. Planning supply around calendar months rather than seven-day cycles is where the confusion usually starts.

What the pen's in-use window actually allows

Once you've taken the first dose from a Mounjaro KwikPen, the clock starts on its in-use storage period. The exact room-temperature window is stated in the patient information leaflet and the SmPC published on the electronic Medicines Compendium, not something to rely on memory for, because the window is shorter than most people assume. Refrigeration extends that window, but the pen cannot be used indefinitely once it has been opened.

None of this creates room to make the pen last longer than 30 days. The storage rules govern safety after opening, not the dosing interval between injections. Attempting to draw extra doses or use a pen beyond its specified in-use period is both unsafe and contrary to the licensed guidance. If you're unsure whether your current pen is still within its window, the right move is to check the leaflet and, if in doubt, contact your prescriber before injecting.

There's a related question worth distinguishing here: whether a pen that has been stored correctly might go off before you reach the fourth dose. That's a separate concern covered in detail on this page about whether Mounjaro goes off after 30 days. The short version is that storage conditions matter more than the calendar date, but both have limits.

When the 28-day cycle causes a genuine gap in supply

The gap between 28-day pens and calendar months becomes a real problem when repeat orders aren't timed to the dosing cycle. Order by calendar month and you'll find yourself two or three days short every time, over six months, that's nearly a full missed dose's worth of disruption.

The cleaner approach is to count from your first injection date and order your next pen to arrive before day 28, not at the end of the month. At nume, the same-day dispatch and free next-working-day tracked delivery through DPD means that ordering a few days early is straightforward, place your order by 12pm Monday to Friday and, once a prescriber has reviewed it, it goes the same day.

Every repeat order at nume involves a fresh clinical review before dispatch. That review is done by a real GPhC-registered prescriber, not automated software. It's also the right moment to flag if the timing of your current schedule isn't working for you. Our page on Mounjaro and the 30-day supply question breaks down the ordering cycle in more practical terms if you want the full picture before your next review.

What to do if Mounjaro stops feeling effective before your next pen arrives

Some people find that by week four, tirzepatide's effect on appetite feels less pronounced than it did in weeks two and three. This is not the same as the medicine going off or the dose being wrong, it reflects the natural trough in the drug's plasma concentration as the seven-day cycle nears its end. It is normal and expected. Researchers have also been exploring tirzepatide's effects beyond weight loss, and the emerging evidence on tirzepatide and MASH illustrates how the medicine's metabolic mechanisms are being studied across a range of liver and metabolic conditions.

What it should not prompt you to do is inject early, split doses, or use any remaining medicine in a way not prescribed. If you feel the current dose is genuinely no longer working rather than just approaching its weekly trough, that is worth discussing with your prescriber at the next review. Read more about Mounjaro no longer working to understand the difference between a timing trough and a response plateau, and what a prescriber looks at when considering whether a dose increase is appropriate.

For a broader overview of how tirzepatide works and what the treatment journey looks like from start to finish, the tirzepatide information page covers the mechanism, evidence base, and what clinical trials showed in terms of average weight reduction over 72 weeks, published in the New England Journal of Medicine. The Mounjaro overview is the place to go for UK-specific licensing, eligibility, and the practical side of treatment. And if you're weighing up the cost of keeping supply running month to month, the Mounjaro price comparison page sets out what private treatment typically costs in the UK, including what a transparent all-in price should cover.

If you have questions about your own timing, doses, or what happens after 30 days on Mounjaro, the best place to resolve them is a conversation with a prescriber who can see your full clinical picture. Speak to our prescribers, it costs nothing and takes a few minutes to start.